April 17 (UPI) -- Researchers have identified a potential new treatment to reduce the effects of intracerebral hemorrhage, or ICH, a severe form of stroke causing blood vessels to burst and bleed into the brain, which can lead to life-threatening edema and neuroinflammation.
Researchers at the Barrow Neurological Institute at St. Joseph's Hospital and Medical Center in Phoenix, Ariz., found that a ligand, a molecule that binds another molecule, of the TPSO protein called etifoxine reduces the inflammation and brain edema in mice induced with ICH.